Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1989-4-6
pubmed:abstractText
In order to determine the specificity of the interaction between thrombin and glia-derived nexin (GdN), the inactivation of proteolytically modified human thrombin species by GdN has been studied. The second-order rate constants for the inactivation of alpha-, beta T-, gamma T- and epsilon-thrombin by GdN were 1.41, 0.63, 0.33 and 1.91 microM-1.s-1 respectively. The kinetic properties of gdN were also investigated in the presence of different types of heparin, fractionated according to antithrombin III-binding affinity. Association rate constants of both gdN and antithrombin III with alpha-thrombin were obtained using unfractionated, low- and high-affinity heparin types. The different heparin types gave optimal rates of inhibition at similar heparin concentrations for both inhibitors. At optimal heparin concentrations, the rate of inactivation of alpha-thrombin by GdN was 0.5-1.2 nM-1.s-1, which suggests that, under these conditions, the interaction is diffusion-controlled.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-1267803, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-1278445, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3005304, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3026312, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3102483, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3110143, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3121595, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3378050, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3394115, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3427015, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3427019, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3584126, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3663613, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3691497, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3768302, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3782075, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3800906, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3813534, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3846593, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-3997857, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-4065100, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-410640, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-4352661, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-4737291, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-4738234, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6183992, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6193754, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6328267, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6420409, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6582486, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6643505, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6693405, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6698980, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6838889, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-687588, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6895893, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6935668, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-6943974, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-7023326, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-7083257, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-7085630, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-7174671, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-7462246, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-78728, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-836327, http://linkedlifedata.com/resource/pubmed/commentcorrection/2920011-952516
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
257
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
191-6
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Effect of heparin on the glia-derived-nexin-thrombin interaction.
pubmed:affiliation
Friedrich Miescher-Institut, Basel, Switzerland.
pubmed:publicationType
Journal Article